Expert Interview
Discussing the potential of Freenome's PREEMPT CRC blood-based test for early detection of colorectal cancer
Ticker(s): FREENOME HOLDINGS, GH, EXASInstitution: NYU Langone
- Adjunct Assistant Professor of Gastroenterology/Hepatology, Department of Medicine at NYU Grossman Long Island School of Medicine
- Manages 75 patients with MASH annually
- Clinical and research interest in Inflammatory Bowel Disease and Fatty Liver Disease
How many colorectal cancer screenings to you provide monthly?
Added By: ben_adminWhat alternatives to colonoscopies do you recommend for CRC screenings?
Added By: ben_adminHow does the Freenome CRC blood test compare to the Shield assay from Guardiant Health and the Cologuard test from Exact Sciences?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
